On Friday, June 5, faculty and graduating medical students were recognized for extraordinary achievements at the annual Geisel School of Medicine Awards Ceremony. Held in the Hopkins Center’s Moore Theater, the event honored excellence in academic achievement, research, community service, teaching, and much more.
Archive for 2015
Geisel Celebrates Class of 2015 MD Graduates
The Geisel School of Medicine at Dartmouth celebrated the accomplishments of 88 new graduates of its MD program during Class Day ceremonies on Saturday, June 6 at Dartmouth’s Leede Arena.
Rick Warren & Joni Eareckson Tada Weigh in on California’s Newest Assisted Suicide Bill
Christian Examiner – Quotes Ira Byock, emeritus professor of medicine and of community and family medicine, from an article in the Los Angeles Times on physician-assisted suicide and how writing prescriptions for lethal medications may put already vulnerable people at risk.
MTV generation faces a rude retirement wake-up call
MSN Money (via Main Street) – References the recent study on the state of Social Security by Samir Soneji, assistant professor of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, and Harvard researchers, which forecasts that Social Security funds will be depleted by 2033. The article states that Generation X, whose ages range from 35 – 50 years old, may not benefit from the program.
At the Hospitals: Geisel Professor Honored
Valley News – Seddon Savage, associate professor of anesthesiology at Geisel and chairwoman of the New Hampshire Governor’s Commission Task Force on Opioids, has received the American Pain Society’s distinguished service award.
Democrats Shouldn’t Endorse Suicide
Politico – An article by Ira Byock, emeritus professor of medicine and of community and family medicine, on the embrace of physician-assisted suicide by progressives as their political response to needless suffering of seriously ill people. Byock comments on the current state of the American hospice industry, and how two-thirds of America’s hospices now belong to for-profit companies, many traded on Wall Street.
Sell a disease to sell a drug
Washington Post – An opinion piece by Steven Woloshin and Lisa Schwartz, both professors of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice at Geisel, on how the Food and Drug Administration is pushing back against the over-prescribing of testosterone.
Graceful Health: Bad bugs of summer
Brattleboro Reformer – An article by Kenneth Rudd, assistant professor of community and family medicine, on insects that spread diseases in the northeast and facts associated with how the diseases are transmitted. “Some bugs are fascinating and beautiful, some are simply a nuisance. Of more concern, though, are bugs that spread disease. While it’s important not to overreact or hide indoors, it’s equally important to have reliable facts,” says Rudd
Your Next Prescription Could Be a Genome Sequence
Huffington Post via Techonomy – Quotes Gregory Tsongalis, professor of pathology, on the use of genome sequencing to improve patient care. Looking ahead, Tsongalis sees every indication that genome sequencing will become a mainstay in hospitals, and he thinks advances in the field will keep pouring in.
Drug Derived From Scorpion Venom Will Target Brain Cancer in Kids
Seattle Times – Quotes David Roberts, professor of surgery and neurology, on news that Seattle Children’s Hospital will be testing a new dye derived from scorpion venom that lights up cancer cells so surgeons can see — and remove — deadly brain tumors. Roberts and other colleagues have also been testing a similar drug compound, 5-aminolevulinic acid (5-ALA), which targets glial tumors.

